2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
- PMID: 37137593
- DOI: 10.1016/j.jacc.2023.03.393
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
Keywords: ACC Expert Consensus Decision Pathway; cardiomyopathy; dyspnea; edema; guideline-directed medical therapy; heart failure with preserved ejection fraction.
Similar articles
-
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024. Epub 2024 Mar 8. J Am Coll Cardiol. 2024. PMID: 38466244 No abstract available.
-
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.J Am Coll Cardiol. 2021 Feb 16;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022. Epub 2021 Jan 11. J Am Coll Cardiol. 2021. PMID: 33446410 No abstract available.
-
2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee.J Am Coll Cardiol. 2023 Jan 24;81(3):292-317. doi: 10.1016/j.jacc.2022.08.754. Epub 2022 Oct 25. J Am Coll Cardiol. 2023. PMID: 36307329 No abstract available.
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1. J Am Coll Cardiol. 2022. PMID: 35379504
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1. Circulation. 2022. PMID: 35363500 Review.
Cited by
-
An autopsy case of constrictive pericarditis following open chest surgery with severe pulmonary hypertension treated as HFpEF.J Cardiol Cases. 2024 Aug 14;30(5):154-156. doi: 10.1016/j.jccase.2024.08.001. eCollection 2024 Nov. J Cardiol Cases. 2024. PMID: 39534305 Free PMC article.
-
Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures.US Cardiol. 2024 Oct 14;18:e17. doi: 10.15420/usc.2023.21. eCollection 2024. US Cardiol. 2024. PMID: 39508003 Free PMC article. Review.
-
Sodium glucose cotransporter 2 inhibitors in the management of heart failure: Veni, Vidi, and Vici.World J Cardiol. 2024 Oct 26;16(10):550-563. doi: 10.4330/wjc.v16.i10.550. World J Cardiol. 2024. PMID: 39492976 Free PMC article. Review.
-
Predicting 30-Day and 1-Year Mortality in Heart Failure with Preserved Ejection Fraction (HFpEF).medRxiv [Preprint]. 2024 Oct 16:2024.10.15.24315524. doi: 10.1101/2024.10.15.24315524. medRxiv. 2024. PMID: 39484276 Free PMC article. Preprint.
-
Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial.Cardiovasc Diabetol. 2024 Oct 22;23(1):373. doi: 10.1186/s12933-024-02463-0. Cardiovasc Diabetol. 2024. PMID: 39438942 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
